Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs

ChemoMetec A/S

03/11/2026 09:40

Overview
Denmark cell counting instrument maker's Q1 2026/27 revenue rose 28% yr/yr to DKK 160 mln
Company raised full-year revenue and EBITDA guidance on strong demand, lower costs
Q1 EBITDA margin improved to 63% from 55% a year earlier

Outlook
ChemoMetec raises 2026/27 revenue guidance to DKK 570-605 mln from DKK 560-590 mln
Company lifts 2026/27 EBITDA outlook to DKK 335-360 mln from DKK 330-345 mln
Company cites higher-than-expected instrument demand and lower cost base for upgraded outlook

Result Drivers
STRONG INSTRUMENT DEMAND - Co said higher-than-expected demand for its instruments, especially the NC-203, supported results
LOWER COST BASE - Co said results benefited from a lower-than-expected cost base

Company press release: ID:nGNE75m5Rl

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
 
DKK 160 mln
 

Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Chemometec A/S is DKK660.00, about 6.5% above its November 2 closing price of DKK619.50
The stock recently traded at 42 times the next 12-month earnings vs. a P/E of 33 three months ago

Reuters Recommended Reads
Nov 2 - Denmark medical devices maker Coloplast's Q4 revenue rises
Nov 3 - Denmark's Solar Q3 revenue rises on organic growth 
Nov 2 - IDEXX Laboratories Q3 revenue beats estimates, lifts FY profit outlook 

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)